2049-3002

Cancer & Metabolism

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 358 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact358 DOIs
2

Add abstracts to 274 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact274 DOIs
3

Add license metadata to 153 records

License metadata tells indexers and readers how each article may be reused.

Medium impact153 DOIs

DOIs for this ISSN

Showing the top 5 of 465 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Mitochondrial reactive oxygen species and cancer (10.1186/2049-3002-2-17)
Abstract ORCID License
211.86 667
2 Metformin directly acts on mitochondria to alter cellular bi… (10.1186/2049-3002-2-12)
Abstract ORCID License
193.48 379
3 Adipocyte lipolysis links obesity to breast cancer growth: a… (10.1186/s40170-016-0163-7)
Abstract ORCID License
192.70 370
4 Hypoxia signaling pathways in cancer metabolism: the importa… (10.1186/2049-3002-2-3)
Abstract ORCID License
180.36 253
5 Inhibition of fatty acid desaturation is detrimental to canc… (10.1186/s40170-016-0146-8)
Abstract ORCID License
175.98 221
6 Metabolic reprogramming induced by ketone bodies diminishes… (10.1186/2049-3002-2-18)
Abstract ORCID License
174.63 212
7 Quantitative analysis of acetyl-CoA production in hypoxic ca… (10.1186/2049-3002-2-23)
Abstract ORCID License
173.85 207
8 Defects in mitochondrial metabolism and cancer (10.1186/2049-3002-2-10)
Abstract ORCID License
173.38 204
9 Succinate dehydrogenase inhibition leads to epithelial-mesen… (10.1186/2049-3002-2-21)
Abstract ORCID License
165.91 162
10 Targeting mitochondrial complex I using BAY 87-2243 reduces… (10.1186/s40170-015-0138-0)
Abstract ORCID License
163.85 152
11 Separation of metabolic supply and demand: aerobic glycolysi… (10.1186/2049-3002-2-7)
Abstract ORCID License
161.65 142
12 Warburg effect(s)—a biographical sketch of Otto Warburg and… (10.1186/s40170-016-0145-9)
Abstract ORCID License
161.65 142
13 GLUT3 is induced during epithelial-mesenchymal transition an… (10.1186/2049-3002-2-11)
Abstract ORCID License
160.25 136
14 Metabolic and transcriptional profiling reveals pyruvate deh… (10.1186/2049-3002-2-20)
Abstract ORCID License
158.04 127
15 The α-ketoglutarate dehydrogenase complex in cancer metaboli… (10.1186/s40170-017-0165-0)
Abstract ORCID License
156.21 120
16 Integration of omics: more than the sum of its parts (10.1186/s40170-016-0143-y)
Abstract ORCID License
151.59 104
17 Endothelial cell metabolism: parallels and divergences with… (10.1186/2049-3002-2-19)
Abstract ORCID License
150.65 101
18 TIGAR, TIGAR, burning bright (10.1186/2049-3002-2-1)
Abstract ORCID License
145.46 86
19 Novel drugs that target the metabolic reprogramming in renal… (10.1186/s40170-016-0154-8)
Abstract ORCID License
140.63 74
20 The action of β-hydroxybutyrate on the growth, metabolism an… (10.1186/s40170-017-0166-z)
Abstract ORCID License
138.84 70
21 Metabolic clusters of breast cancer in relation to gene- and… (10.1186/s40170-016-0152-x)
Abstract ORCID License
136.96 66
22 SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins… (10.1186/2049-3002-2-15)
Abstract ORCID License
136.47 65
23 Putting the pieces together: How is the mitochondrial pathwa… (10.1186/2049-3002-2-16)
Abstract ORCID License
131.69 56
24 Weight control interventions improve therapeutic efficacy of… (10.1186/s40170-016-0162-8)
Abstract ORCID License
128.70 51
25 Knockout of Vdac1 activates hypoxia-inducible factor through… (10.1186/s40170-015-0133-5)
Abstract ORCID License
126.09 47
26 Mitochondria as biosynthetic factories for cancer proliferat… (10.1186/s40170-015-0128-2)
Abstract ORCID
125.93 329
27 Discovery of a PFKFB3 inhibitor for phase I trial testing th… (10.1186/2049-3002-2-s1-p14)
Abstract References ORCID License
125.53 17
28 Decoding the dynamics of cellular metabolism and the action… (10.1186/2049-3002-2-9)
Abstract ORCID License
123.26 43
29 Mitophagy and cancer (10.1186/s40170-015-0130-8)
Abstract ORCID
119.55 245
30 13C-labeled biochemical probes for the study of cancer metab… (10.1186/s40170-015-0136-2)
Abstract ORCID License
119.33 38
31 Sterol regulatory element binding protein-dependent regulati… (10.1186/2049-3002-1-3)
ORCID License
119.01 239
32 Balancing glycolytic flux: the role of 6-phosphofructo-2-kin… (10.1186/2049-3002-1-8)
Abstract ORCID
118.92 238
33 Mitochondria and cancer (10.1186/2049-3002-2-8)
Abstract ORCID License
117.62 36
34 Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and… (10.1186/2049-3002-1-19)
Abstract ORCID
117.22 220
35 Metabolomics and metabolic pathway networks from human color… (10.1186/s40170-016-0151-y)
Abstract ORCID
116.72 215
36 Mathematical models of cancer metabolism (10.1186/s40170-015-0140-6)
Abstract ORCID License
115.81 34
37 Acidosis induces reprogramming of cellular metabolism to mit… (10.1186/2049-3002-1-23)
ORCID License
114.39 193
38 Bridging the gap between non-targeted stable isotope labelin… (10.1186/s40170-016-0150-z)
Abstract ORCID License
113.89 32
39 A strategically designed small molecule attacks alpha-ketogl… (10.1186/2049-3002-2-4)
ORCID License
111.39 168
40 The metabolic demands of cancer cells are coupled to their s… (10.1186/2049-3002-1-20)
ORCID License
111.14 166
41 PGC-1α supports glutamine metabolism in breast cancer (10.1186/2049-3002-1-22)
ORCID License
109.79 156
42 A rapid method for quantifying free and bound acetate based… (10.1186/s40170-016-0157-5)
Abstract ORCID License
109.68 28
43 Metabolic profiling of triple-negative breast cancer cells r… (10.1186/s40170-017-0168-x)
Abstract ORCID
109.23 152
44 Bortezomib resistance in multiple myeloma is associated with… (10.1186/s40170-017-0169-9)
Abstract License
108.80 149
45 Malonate as a ROS product is associated with pyruvate carbox… (10.1186/s40170-016-0155-7)
Abstract ORCID License
108.54 27
46 Loss of HSulf-1 promotes altered lipid metabolism in ovarian… (10.1186/2049-3002-2-13)
Abstract ORCID License
106.12 25
47 Targeting glutamine metabolism sensitizes pancreatic cancer… (10.1186/s40170-015-0137-1)
Abstract ORCID
105.19 126
48 Metabolic requirements for cancer cell proliferation (10.1186/s40170-016-0156-6)
Abstract ORCID
103.96 119
49 Treatment of glioma patients with ketogenic diets: report of… (10.1186/s40170-015-0129-1)
Abstract ORCID
101.87 108
50 Calorie restriction and cancer prevention: a mechanistic per… (10.1186/2049-3002-1-10)
Abstract ORCID
101.67 107